Cambiar Investors LLC Lowers Stock Holdings in CME Group Inc. (NASDAQ:CME)

Cambiar Investors LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 1.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 284,702 shares of the financial services provider’s stock after selling 3,433 shares during the period. CME Group accounts for approximately 2.4% of Cambiar Investors LLC’s portfolio, making the stock its 3rd largest holding. Cambiar Investors LLC’s holdings in CME Group were worth $62,819,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Norden Group LLC bought a new position in shares of CME Group during the first quarter valued at approximately $274,000. Private Advisor Group LLC grew its stake in shares of CME Group by 3.9% in the first quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock worth $989,000 after acquiring an additional 172 shares during the last quarter. Prosperity Consulting Group LLC purchased a new stake in shares of CME Group in the first quarter worth $237,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of CME Group by 33.4% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 105,960 shares of the financial services provider’s stock valued at $22,812,000 after buying an additional 26,536 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in shares of CME Group by 32.0% during the first quarter. Janney Montgomery Scott LLC now owns 52,167 shares of the financial services provider’s stock valued at $11,231,000 after buying an additional 12,653 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. The Goldman Sachs Group raised their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Piper Sandler raised their price objective on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Citigroup raised their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Finally, Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $222.73.

CME Group Stock Performance

NASDAQ CME opened at $223.61 on Friday. The stock has a market capitalization of $80.52 billion, a PE ratio of 23.51, a P/E/G ratio of 5.72 and a beta of 0.55. The business has a 50 day simple moving average of $220.69 and a two-hundred day simple moving average of $209.46. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the business posted $2.25 EPS. On average, research analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is presently 48.37%.

Insider Buying and Selling at CME Group

In other CME Group news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the transaction, the insider now owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,221 shares of company stock worth $3,351,895 in the last quarter. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.